Novo Nordisk A/S ADR buy fenjal
Start price
29.05.23
/
50%
€154.00
Target price
29.05.24
-
Performance (%)
10.06%
End price
16.08.23
€169.50
Summary
This prediction ended on 16.08.23 with a price of €169.50. The BUY prediction by fenjal finished with a performance of 10.06%. fenjal has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -1.277% | -1.277% |
| iShares Core DAX® | 0.000% | -2.064% |
| iShares Nasdaq 100 | 0.626% | -2.884% |
| iShares Nikkei 225® | 1.568% | -5.892% |
| iShares S&P 500 | 0.334% | -2.281% |
According to fenjal what are the pros and cons of Novo Nordisk A/S ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by fenjal for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Buy Novo Nordisk A/S ADR
In the thread Trading Novo Nordisk A/S ADR
Stopped prediction by fenjal for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€37.03
09.05.17
09.05.17
€42.00
18.09.17
18.09.17
10.53%
18.09.17
18.09.17
Could be worthwhile Investment >10% per year
